TITLE

Cardiovascular Drugs

AUTHOR(S)
Goodwin, J. F.
PUB. DATE
August 1965
SOURCE
British Medical Journal;8/7/1965, Vol. 2 Issue 5457, p349
SOURCE TYPE
Review
DOC. TYPE
Book Review
ABSTRACT
No abstract available.
ACCESSION #
64059715

 

Related Articles

  • Cardiovascular Pharmacotherapy 2010. Cohn, Jay N. // Cardiovascular Drugs & Therapy;Aug2010, Vol. 24 Issue 4, p297 

    A foreword to "Cardiovascular Drugs & Therapy" is presented.

  • Cardiovascular Drugs (Book).  // Annals of Internal Medicine;Nov84, Vol. 101 Issue 5, p726 

    Reviews the book 'Cardiovascular Drugs,' edited by Alexander Scriabine.

  • An update on the new drugs your dispensing now. Rodman, Morton J. // RN;May84, Vol. 47 Issue 5, p83 

    Highlights the developments in drug therapy. Cardiovascular drugs; Antihypertensive agents; Diuretics.

  • The nurse's guide to cardiovascular drugs. Yacone, Linda Ann // RN;Aug88, Vol. 51 Issue 8, p36 

    Discusses guidelines for nurses about drugs for cardiovascular diseases. Types of cardiovascular diseases and cardiovascular disease drugs; Mechanisms of cardiac glycosides; Information on vasodilators.

  • DRUGS FOR WHICH PEOPLE ARE WAITING. Korneyev, V.; Tutorskaya, S. // World Affairs;Jun89, Vol. 152 Issue 1, p57 

    Comments on the issues related to the supply of cardiovascular drugs in Russia. Percentage of cardiovascular drugs produced for the year 1988; Scarcity in the supply of domestic drugs; Strategy in eliminating the shortage of cardiovascular drugs.

  • LIVALO.  // Physician Assistants' Prescribing Reference;Fall2010, Vol. 17 Issue 3, pA.10 

    The article evaluates the cardiovascular drug Livalo from Kowa and Lilly.

  • Cardiovascular Drug Therapy (Book).  // Annals of Internal Medicine;4/1/91, Vol. 114 Issue 7, p610 

    Reviews the book 'Cardiovascular Drug Therapy,' by Franz H. Messerli.

  • Drug Therapy in Cardiovascular Disease (Book). Conn Jr., Hadley L. // Annals of Internal Medicine;Oct86, Vol. 105 Issue 4, p644 

    Reviews the book 'Drug Therapy in Cardiovascular Disease,' by Adam Schneeweiss.

  • Vorapaxar (Zontivity) for the Prevention of Thrombotic Cardiovascular Events. BARRY, KATHLEEN A.; SOMERVILLE, NICHOLAS J. // American Family Physician;8/15/2015, Vol. 92 Issue 4, p304 

    The article reviews the antiplatelet drug Vorapaxar (Zontivity) for the prevention of thrombotic cardiovascular events.

  • The Use of Celebrex and Vioxx in Patients with Heart Disease.  // Access;Dec2001, Vol. 15 Issue 10, p4 

    Examines the efficacy of antiinflammatory drugs in patients with cardiovascular diseases. Reduction of annualized heart attack rate; Concerns on the cardiovascular risk and benefits; Precautions on drug intake.

Share

Read the Article

Other Topics